Struggling with blind pimples? Learn how to treat cystic acne fast with dermatologist-approved products and proven at-home ...
Bolton Wanderers boss Steven Schumacher insists neither Josh Sheehan or Thierry Gale will hold a grudge about being subbed at ...
Strategic collaboration expands taletrectinib global reach with a leading oncology partnerEisai will receive exclusive development, registration and commercialization rights for taletrectinib for the ...
Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...
Bolton Wanderers boss Steven Schumacher insists neither Josh Sheehan or Thierry Gale will hold a grudge about being subbed at Peterborough.
Looking for a safe, empowering space to hit your fitness goals? Finding the best women’s gym for how and when you want to ...
$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...
PLYMOUTH MEETING, Pa.-- (BUSINESS WIRE)--January 12, 2026-- ...
ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in psoriasis and quarterly ...
The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...
WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...
Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback